Skip to main content
PMC home page
Thorax logoLink to Thorax
. 1993 Aug;48(8):785–789. doi: 10.1136/thx.48.8.785

Factors of importance for the long term prognosis after hospital treated pneumonia.

J U Hedlund 1, A B Ortqvist 1, M E Kalin 1, F Granath 1
PMCID: PMC464701  PMID: 8211867

Abstract

BACKGROUND--Elderly patients admitted to hospital for community acquired pneumonia have a high risk of recurrence of pneumonia and of death during the years after discharge. In this study potential factors of importance for the long term prognosis after hospital treated pneumonia were retrospectively investigated. METHODS--A total of 241 patients (103 men) with a mean age of 60 (range 18-102) years discharged from hospital after treatment for community acquired pneumonia were studied. After an average follow up period of 31 months, 18 independent variables present during hospital treatment of the initial pneumonia were examined for association with the following end points: recurrence of pneumonia, death from any cause, and death from pneumonia. RESULTS--Age adjusted analysis showed that systemic treatment with corticosteroids correlated significantly with recurrence of pneumonia and with death. The presence of low serum albumin levels on admission or colonisation of the respiratory tract with Gram negative enteric bacteria seemed to be important negative prognostic factors for the outcome during pneumonia recurrences after discharge. CONCLUSIONS--Patients who are admitted to hospital with pneumonia are at risk of subsequent pneumonia and death after discharge. This risk seems to be even higher in patients who are treated with corticosteroids systemically, who have a low serum albumin level on admission, or who become colonised in the respiratory tract with Gram negative enteric bacteria during their hospital stay.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alexander E. R., Foy H. M., Kenny G. E., Kronmal R. A., McMahan R., Clarke E. R., MacColl W. A., Grayston J. T. Pneumonia due to Mycoplasma pneumoniae. Its incidence in the membership of a co-operative medical group. N Engl J Med. 1966 Jul 21;275(3):131–136. doi: 10.1056/NEJM196607212750303. [DOI] [PubMed] [Google Scholar]
  2. Brown R. O., Bradley J. E., Bekemeyer W. B., Luther R. W. Effect of albumin supplementation during parenteral nutrition on hospital morbidity. Crit Care Med. 1988 Dec;16(12):1177–1182. doi: 10.1097/00003246-198812000-00002. [DOI] [PubMed] [Google Scholar]
  3. Delmi M., Rapin C. H., Bengoa J. M., Delmas P. D., Vasey H., Bonjour J. P. Dietary supplementation in elderly patients with fractured neck of the femur. Lancet. 1990 Apr 28;335(8696):1013–1016. doi: 10.1016/0140-6736(90)91073-j. [DOI] [PubMed] [Google Scholar]
  4. Eliasson O., Hoffman J., Trueb D., Frederick D., McCormick J. R. Corticosteroids in COPD. A clinical trial and reassessment of the literature. Chest. 1986 Apr;89(4):484–490. doi: 10.1378/chest.89.4.484. [DOI] [PubMed] [Google Scholar]
  5. Fekety F. R., Jr, Caldwell J., Gump D., Johnson J. E., Maxson W., Mulholland J., Thoburn R. Bacteria, viruses, and mycoplasmas in acute pneumonia in adults. Am Rev Respir Dis. 1971 Oct;104(4):499–507. doi: 10.1164/arrd.1971.104.4.499. [DOI] [PubMed] [Google Scholar]
  6. Fekety F. R., Jr, Caldwell J., Gump D., Johnson J. E., Maxson W., Mulholland J., Thoburn R. Bacteria, viruses, and mycoplasmas in acute pneumonia in adults. Am Rev Respir Dis. 1971 Oct;104(4):499–507. doi: 10.1164/arrd.1971.104.4.499. [DOI] [PubMed] [Google Scholar]
  7. Foy H. M., Kenny G. E., Cooney M. K., Allan I. D. Long-term epidemiology of infections with Mycoplasma pneumoniae. J Infect Dis. 1979 Jun;139(6):681–687. doi: 10.1093/infdis/139.6.681. [DOI] [PubMed] [Google Scholar]
  8. Hedlund J. U., Ortqvist A. B., Kalin M., Scalia-Tomba G., Giesecke J. Risk of pneumonia in patients previously treated in hospital for pneumonia. Lancet. 1992 Aug 15;340(8816):396–397. doi: 10.1016/0140-6736(92)91473-l. [DOI] [PubMed] [Google Scholar]
  9. Herrmann F. R., Safran C., Levkoff S. E., Minaker K. L. Serum albumin level on admission as a predictor of death, length of stay, and readmission. Arch Intern Med. 1992 Jan;152(1):125–130. [PubMed] [Google Scholar]
  10. Hook E. W., 3rd, Horton C. A., Schaberg D. R. Failure of intensive care unit support to influence mortality from pneumococcal bacteremia. JAMA. 1983 Feb 25;249(8):1055–1057. [PubMed] [Google Scholar]
  11. Ingenbleek Y., Carpentier Y. A. A prognostic inflammatory and nutritional index scoring critically ill patients. Int J Vitam Nutr Res. 1985;55(1):91–101. [PubMed] [Google Scholar]
  12. Karalus N. C., Cursons R. T., Leng R. A., Mahood C. B., Rothwell R. P., Hancock B., Cepulis S., Wawatai M., Coleman L. Community acquired pneumonia: aetiology and prognostic index evaluation. Thorax. 1991 Jun;46(6):413–418. doi: 10.1136/thx.46.6.413. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Lipsky B. A., Boyko E. J., Inui T. S., Koepsell T. D. Risk factors for acquiring pneumococcal infections. Arch Intern Med. 1986 Nov;146(11):2179–2185. [PubMed] [Google Scholar]
  14. Marrie T. J., Durant H., Yates L. Community-acquired pneumonia requiring hospitalization: 5-year prospective study. Rev Infect Dis. 1989 Jul-Aug;11(4):586–599. doi: 10.1093/clinids/11.4.586. [DOI] [PubMed] [Google Scholar]
  15. Ortqvist A., Hammers-Berggren S., Kalin M. Respiratory tract colonization and incidence of secondary infection during hospital treatment of community-acquired pneumonia. Eur J Clin Microbiol Infect Dis. 1990 Oct;9(10):725–731. doi: 10.1007/BF02184684. [DOI] [PubMed] [Google Scholar]
  16. Ortqvist A., Hedlund J., Grillner L., Jalonen E., Kallings I., Leinonen M., Kalin M. Aetiology, outcome and prognostic factors in community-acquired pneumonia requiring hospitalization. Eur Respir J. 1990 Nov;3(10):1105–1113. [PubMed] [Google Scholar]
  17. Pressac M., Vignoli L., Aymard P., Ingenbleek Y. Usefulness of a prognostic inflammatory and nutritional index in pediatric clinical practice. Clin Chim Acta. 1990 Apr 30;188(2):129–136. doi: 10.1016/0009-8981(90)90157-n. [DOI] [PubMed] [Google Scholar]
  18. Rodrigues J., Niederman M. S., Fein A. M., Pai P. B. Nonresolving pneumonia in steroid-treated patients with obstructive lung disease. Am J Med. 1992 Jul;93(1):29–34. doi: 10.1016/0002-9343(92)90676-3. [DOI] [PubMed] [Google Scholar]
  19. Sullivan R. J., Jr, Dowdle W. R., Marine W. M., Hierholzer J. C. Adult pneumonia in a general hospital. Etiology and host risk factors. Arch Intern Med. 1972 Jun;129(6):935–942. [PubMed] [Google Scholar]
  20. Venkatesan P., Gladman J., Macfarlane J. T., Barer D., Berman P., Kinnear W., Finch R. G. A hospital study of community acquired pneumonia in the elderly. Thorax. 1990 Apr;45(4):254–258. doi: 10.1136/thx.45.4.254. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Wiest P. M., Flanigan T., Salata R. A., Shlaes D. M., Katzman M., Lederman M. M. Serious infectious complications of corticosteroid therapy for COPD. Chest. 1989 Jun;95(6):1180–1184. doi: 10.1378/chest.95.6.1180. [DOI] [PubMed] [Google Scholar]
  22. Woodhead M. A., Macfarlane J. T., McCracken J. S., Rose D. H., Finch R. G. Prospective study of the aetiology and outcome of pneumonia in the community. Lancet. 1987 Mar 21;1(8534):671–674. doi: 10.1016/s0140-6736(87)90430-2. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES